Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

KaloBios Pharmaceuticals, Sanofi Pasteur partner in development of KB001 biologic for Pa infections

KaloBios Pharmaceuticals, Inc. today announced an agreement with Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, for the development and commercialization of KB001, an investigational new biologic for the treatment or prevention of Pseudomonas aeruginosa (Pa) infections. Sanofi Pasteur will be responsible for the development and commercialization of KB001 and initially focus on hospital indications, including the prevention of Pa pneumonias in mechanically ventilated patients.

11 Jan 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Lessons learned from the first 13 children at Johns Hopkins Children's Center to become critically ill from the H1N1 virus show that although all patients survived, serious complications developed quickly, unpredictably, with great variations from patient to patient and with serious need for vigilant monitoring and quick treatment adjustments.

8 Jan 2010

Amira Pharmaceuticals achieves another development milestone in its FLAP program

Amira Pharmaceuticals, Inc. announced today that it has achieved another development milestone in its FLAP program, which is partnered with GlaxoSmithKline. This milestone is related to the successful development of a solid dose formulation, which is critical for future development and commercialization activities.

8 Jan 2010

Ligand Pharmaceuticals receives $1 million as payment from N. V. Organon

Ligand Pharmaceuticals Incorporated announced today that it has received a $1 million milestone payment from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that expired on December 31, 2009.

8 Jan 2010

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.

8 Jan 2010

King Center to host second annual 'Health and Wellness Forum'

The King Center announced that it will officially launch the 2010 MLK Birthday Observance on Saturday, Jan. 9, 2010 by hosting and co-sponsoring its second annual “Health and Wellness Forum.” It is being co-sponsored by a $50,000 grant from Aetna, which also funded last year’s inaugural program.

8 Jan 2010

Sciele Pharma announces the U.S. availability of Adrenaclick

Sciele Pharma, Inc., a Shionogi company, today announced the U.S. availability of Adrenaclick™, a single-dose, epinephrine auto-injector for the emergency treatment for severe allergic reactions (Type I) such as anaphylaxis.

8 Jan 2010

Final health care reform legislation requires comprehensive coverage of smoking cessation treatment

As Congress negotiates a final health care reform bill, lawmakers should seize this unprecedented opportunity to invest in proven measures that prevent costly diseases from occurring in the first place, which will improve health and reduce health care costs. These include measures to prevent and reduce tobacco use, which remains the leading cause of preventable death in the United States, killing more than 400,000 people and costing the nation $96 billion in health care expenditures annually.

8 Jan 2010

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

8 Jan 2010

Positive top-line results from Phase III study of aclidinium bromide announced

orest Laboratories, Inc. and Almirall, S.A. (ALM.MC) today announced positive top-line results from ACCORD COPD I, a three-month Phase III study comparing aclidinium 200µg and 400µg BID versus placebo.

7 Jan 2010

Researchers identify new approach to eliminate side effects of drugs

Researchers at the Stanford University School of Medicine have taken an early step toward identifying a new approach to drug discovery that may eventually yield drugs with fewer side effects.

7 Jan 2010

Nonin Medical to demonstrate Onyx II fingertip pulse oximeter

Nonin Medical, Inc., a leading innovator of physiological monitoring solutions and the inventor of fingertip pulse oximetry, will demonstrate the World's first Continua(TM) Certified Bluetooth® fingertip pulse oximeter, the Onyx® II, Model 9560, as part of the historic first end-to-end Continua(TM) connected health solution.

7 Jan 2010

New research shows breast milk is not as important for mother or child's health

Feeling guilty that you didn't breastfeed your children enough - or at all? Relax. New research shows that breast milk is not as important for either the mother or the child's health.

6 Jan 2010

NSF International develops new protocol for clothes washers

Continuing its mission to protect and improve public health, NSF International today announced the development of a new protocol that certifies allergen reduction performance of residential and commercial, family-sized clothes washers. Whirlpool Corporation is the first company to receive certification with this new protocol for clothes washers.

6 Jan 2010

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Researchers have identified two cellular proteins that are important factors in hepatitis C virus infection, a finding that may result in the approval of new and less toxic treatments for the disease, which can lead to liver cancer and cirrhosis.

6 Jan 2010

H1N1 flu vaccine now available at CVS/pharmacy locations throughout California

CVS/pharmacy announced today that it has expanded the availability of H1N1 flu vaccine to more than 220 stores throughout the State of California.

6 Jan 2010

NQF endorses 70 measures to improve gathering of clinical electronic data

As an incremental step toward wider use of electronic data platforms to measure, report, and improve quality, the National Quality Forum (NQF) has endorsed 70 measures that combine data from two or more common electronic sources such as administrative claims, pharmacy and laboratory systems, and registries.

5 Jan 2010

Androgen receptor plays critical role in wound healing

A molecular receptor pivotal to the action of male hormones such as testosterone also plays a crucial role in the body's ability to heal, report scientists in the December issue of the Journal of Clinical Investigation.

5 Jan 2010

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jan 2010

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from its first clinical trial in patients with chronic obstructive pulmonary disease (COPD).

5 Jan 2010

Asthma News and Research

Further Reading

KaloBios Pharmaceuticals, Sanofi Pasteur partner in development of KB001 biologic for Pa infections

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Amira Pharmaceuticals achieves another development milestone in its FLAP program

Ligand Pharmaceuticals receives $1 million as payment from N. V. Organon

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

King Center to host second annual 'Health and Wellness Forum'

Sciele Pharma announces the U.S. availability of Adrenaclick

Final health care reform legislation requires comprehensive coverage of smoking cessation treatment

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

Positive top-line results from Phase III study of aclidinium bromide announced

Researchers identify new approach to eliminate side effects of drugs

Nonin Medical to demonstrate Onyx II fingertip pulse oximeter

New research shows breast milk is not as important for mother or child's health

NSF International develops new protocol for clothes washers

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

H1N1 flu vaccine now available at CVS/pharmacy locations throughout California

NQF endorses 70 measures to improve gathering of clinical electronic data

Androgen receptor plays critical role in wound healing

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News